If Groucho uses a co-recruited HDAC activity to oppose β-catenin•LEF-1, is this action sufficient to counter endogenous β-catenin and its recruited histone acetyltransferase complexes in colon cancer cells? This evidence concerns the gene LEF1 and colonic neoplasm.